ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency

August 14, 1992

Patients on Hypertension Meds Lived Longer, Analysis Shows

January 31, 2014

In Brief: Fleming New ACCC President, Jennifer Guy President Elect; Rauscher Joins UNIMED Board

April 7, 1989

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012

Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer

August 27, 2010